Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,205 public trials 1,002 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)

NCT02912949

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • The Oncology Institute of Hope and Innovation Cerritos, California, United States
  • University of California Irvine Irvine, California, United States
  • Stanford University Palo Alto, California, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression

NCT05736731

Conditions
Bronchial Neoplasms, CRC, Cancer, +38 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Active, Not Recruiting

Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation

NCT05919537

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • GenesisCare North Shore Sydney, New South Wales, Australia
  • ICON Cancer Centre South Brisbane Brisbane, Queensland, Australia
  • Southern Oncology Clinical Research Unit Adelaide, South Australia, Australia
  • Cabrini Health Malvern, Victoria, Australia
View Trial Details

Related conditions